Exploiting machine learning for end-to-end drug discovery and development
Collaborations Pharmaceuticals (United States) · Rutgers, The State University of New Jersey · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
557
total citations
- FWCI
- 59.02
- Percentile
- 100%
- References
- 96
Citations per year
Authors
8- SESean EkinsCorresponding
Collaborations Pharmaceuticals (United States)
- ACAna C. Puhl
Collaborations Pharmaceuticals (United States)
- KMKimberley M. Zorn
Collaborations Pharmaceuticals (United States)
- TRThomas R. Lane
Collaborations Pharmaceuticals (United States)
- DPDaniel P. Russo
Rutgers, The State University of New Jersey, Collaborations Pharmaceuticals (United States)
Topics & keywords
Topics
Keywords
- Drug discovery
- Leverage (statistics)
- Computer science
- Machine learning
- Repurposing
- Artificial intelligence
- Exploit
- Drug repositioning
No related works found for this paper.